Blog

BrightFocus Foundation Awards $13M for Alzheimer’s and Eye Disease Research In a groundbreaking move to advance medical research, the BrightFocus Foundation has announced the allocation of $13 million in grants to support cutting-edge studies on Alzheimer’s disease and eye diseases. This significant investment underscores the foundation’s commitment to accelerating breakthroughs in neurodegenerative and vision-related conditions, […]

Top Advances in Nonimplant MIGS for Glaucoma Treatment Glaucoma, a leading cause of irreversible blindness worldwide, has seen significant advancements in treatment options over the past decade. Among these, Minimally Invasive Glaucoma Surgery (MIGS) has emerged as a game-changer, offering safer and less invasive alternatives to traditional surgeries. While implant-based MIGS devices have gained attention,

TLR4 Deficiency Does Not Affect Glaucoma Progression in Mice Glaucoma is a leading cause of irreversible blindness worldwide, characterized by progressive optic nerve damage and retinal ganglion cell (RGC) loss. While elevated intraocular pressure (IOP) is a major risk factor, the underlying molecular mechanisms remain incompletely understood. Recent studies have explored the role of innate

Top Science and Technology Breakthroughs of 2025 The year 2025 is shaping up to be a landmark period for scientific and technological advancements. From artificial intelligence to space exploration, groundbreaking innovations are set to redefine industries and improve lives. In this article, we’ll explore the most exciting breakthroughs expected in 2025, offering a glimpse into

Reasons for Loss to Follow-Up in Thai Glaucoma Patients and Suspects Glaucoma is a leading cause of irreversible blindness worldwide, and Thailand is no exception. Early detection and consistent follow-up are crucial to preventing vision loss. However, many Thai glaucoma patients and suspects fail to return for scheduled appointments, leading to disease progression and poorer

Surgery May Alleviate Pediatric Uveitic Glaucoma Symptoms, Study Shows Pediatric uveitic glaucoma is a rare but serious condition that can lead to vision loss if left untreated. A recent study has shed light on the effectiveness of surgical interventions in managing this challenging eye disorder. The findings offer hope for parents and caregivers seeking solutions

High HDL Cholesterol May Increase Glaucoma Risk: New Study Reveals For years, high-density lipoprotein (HDL) cholesterol has been celebrated as the “good cholesterol” due to its role in protecting heart health. However, a groundbreaking new study suggests that elevated HDL levels might be linked to an increased risk of glaucoma—a leading cause of irreversible blindness.

Vitamin Supplements May Slow Glaucoma Progression, Study Finds Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While treatments like eye drops, laser therapy, and surgery aim to lower intraocular pressure (IOP), researchers are constantly exploring new ways to slow disease progression. A recent study suggests that vitamin supplements could play

Perfuse Therapeutics Reports Positive Phase 1/2a Results for PER-001 Glaucoma Implant In a significant breakthrough for glaucoma treatment, Perfuse Therapeutics has announced encouraging results from its Phase 1/2a clinical trial for PER-001, a novel implant designed to manage intraocular pressure (IOP) in glaucoma patients. The study demonstrated both safety and efficacy, marking a promising step

How Intraoperative Fluorescein Angiography Enhances RWC 2025 Surgical Outcomes In the rapidly evolving field of surgical medicine, advancements in imaging technologies are revolutionizing patient outcomes. One such breakthrough is intraoperative fluorescein angiography (IFA), a real-time imaging technique that is transforming surgical precision, particularly in complex procedures like those anticipated in the RWC 2025 (Robotic and